The Food and Drug Administration (FDA) has granted Orphan Drug designation to ersodetug (RZ358) for the treatment of hypoglycemia due to tumor hyperinsulinism (HI). Tumor HI is a rare condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback